Press release, Helsinki, 26 August 2019 at 9.30 am (EET) Achieve TMS, the second largest TMS group in the US, starts using Nexstim SmartFocus® TMS technology Nexstim Plc (NXTMH:HEX, NXTMS:STO) ...

Press Release, Helsinki, 4 February 2020 at 11.15 am (EET) Nexstim NBT® System with SmartFocus® TMS installed at Mind Matters PsychiatryMD, US Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company ...

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it has sold and installed two TMS systems with SmartFocus® TMS technology to two leading neuroscience institutions in Italy.

Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS System 5 from a new European customer through a distributor. The Nexstim Navigated Brain Stimulation (NBS) System 5 is ...

MORRISVILLE, N.C.--Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today thatNexstim, a leader in navigated stimulation of the brain, has selected the company to ...

Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS System 5 from an existing customer. Nexstim’s NBS (Navigated Brain Stimulation) System 5 is CE marked and FDA approved ...

Nexstim Receives System Order from Distributor in India Nexstim Plc ("Nexstim" or "Company") has received an order for an NBS System 5 through a ...

Nexstim Plc’s (NXTMH:HEX) ("Nexstim" or "Company") US private equity company Nexstim Investments, LLC has signed an agreement regarding a strategic alliance with and a minority ownership in a ...

SAN DIEGO--(BUSINESS WIRE)--Every two seconds someone in the world suffers a stroke. A study from the Rehabilitation Institute of Chicago approached stroke rehabilitation through a new combination of ...

Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of Major ...

Nexstim won FDA clearance for its noninvasive brain stimulation system that treats major depressive disorder. The system is already CE-marked for the treatment of major depression, stroke and chronic ...